¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"muscular type of vein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • renal vein thrombosis
    ÄáÆÏÁ¤¸ÆÇ÷ÀüÁõ, ½ÅÁ¤¸ÆÇ÷ÀüÁõ
  • radicular vein
    »Ñ¸®Á¤¸Æ
  • subclavian vein
    ºøÀ幨Á¤¸Æ, ¼â°ñÇÏÁ¤¸Æ
  • superior mesenteric vein
    À§Ã¢ÀÚ°£¸·Á¤¸Æ, »óÀå°£¸·Á¤¸Æ
  • sylvian vein
    ½Çºñ¿ì½ºÁ¤¸Æ
  • systemic vein
    Àü½ÅÁ¤¸Æ, üÁ¤¸Æ
  • short gastric vein
    ªÀºÀ§Á¤¸Æ
  • sigmoid vein
    ±¸ºÒâÀÚÁ¤¸Æ, ±¸ºÒ°áÀåÁ¤¸Æ
  • smallest cardiac vein
    ÃÖ¼Ò½ÉÀåÁ¤¸Æ
  • ulnar vein
    ÀÚÁ¤¸Æ, ô°ñÁ¤¸Æ
  • umbilical vein
    ¹è²ÅÁ¤¸Æ, Á¦Á¤¸Æ
  • varicose vein
    Á¤¸Æ·ù
  • vein
    Á¤¸Æ
  • vitelline vein
    ³­È²Á¤¸Æ
  • vorticose vein
    ¶Ç¾Æ¸®Á¤¸Æ, ¿ÍÁ¤Á¤¸Æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • type strain
    Ç¥ÁرÕÁÖ
  • type
    Çü, À¯Çü
  • test type
    ½Ã°¢Ç¥, ½ÃÇ¥
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • hepatic portal vein
    °£¹®¸Æ(°£¹®¸Æ).
  • hepatic vein
    °£Á¤¸Æ.
  • hepatic vein thrombosis
    °£Á¤¸ÆÇ÷ÀüÁõ
  • hepatic venous wedge pressure =wedged h.vein pressure
    Æó»ö°£Á¤¸Æ¾Ð( øÍßáÊÜð¡Øæäâ).
  • hypophyseal vein
    ³úÇϼöüÁ¤¸Æ
  • ileocolic vein
    µ¹ÁÖ¸§Ã¢ÀÚÁ¤¸Æ
  • iliolumbar vein
    ¾ûµ¢Ç㸮Á¤¸Æ
  • inferior anastomotic vein
    ¾Æ·¡¿¬°áÁ¤¸Æ
  • inferior basal vein
    ¾Æ·¡¹Ù´ÚÁ¤¸Æ
  • inferior choroidal vein
    ¾Æ·¡¸Æ¶ôÁ¤¸Æ
  • inferior laryngeal vein
    ¾Æ·¡ÈĵÎÁ¤¸Æ
  • inferior mesenteric vein
    ¾Æ·¡Ã¢ÀÚ°£¸·Á¤¸Æ
  • inferior ophthalmic vein
    ¾Æ·¡´«Á¤¸Æ
  • petrosal vein
    ¹ÙÀ§Á¤¸Æ
  • phrenic vein
    Ⱦ°Ý¸·Á¤¸Æ, Ⱦ°ÝÁ¤¸Æ(üô̰ ð¡Øæ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõ ÐÉê×õêñø)
  • neurogenic muscular atrophy
    ½Å°æ¼º ±ÙÀ§Ãà(Áõ).
  • neurospinal muscular atrophy
    ½Å°æÃ´¼ö¼º±ÙÀ§Ãà(~ô±âÐàõÐÉê×õê).
  • oculopharyngeal muscular dystrophy
    ¾È±¸ÀεαÙÀ°ÀÌ¿µ¾çÁõ(±ÙÀ§ÃàÁõ)(äÑϹìÑÔéÐÉë¿ì¶ç½å×ñø(ÐÉê×õêñø))
  • peroneal muscular atrophy
    ºñ°ñ±Ù À§ÃàÁõ(ÝëÍéÐÉê×õêñø).
  • peroneal muscular dystrophy
    ºñ°ñ±ÙÀ§ÃàÁõ(Þ¡ÍéÐÆê×õêñø)
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • pseudohypertrophy,in muscular dystrophy
    ±ÙÀÌ¿µ¾ç(Áõ)ÀÇ ¡­(ÐÉì¶ç½å×(ñø)¡­)
  • skeletal muscular tissue
    °¡·Î¹«´Ì±ÙÀ°Á¶Á÷ [»À´ë±ÙÀ°Á¶Á÷
  • smooth muscular tissue
    ¹Î¹«´Ì±ÙÁ¶Á÷, ÆòȰ±ÙÁ¶Á÷(¡­ðÚòÄ).
  • spinal muscular atrophy
    ô¼ö±ÙÀ§Ãà(Áõ)(¡­ÐÉê×õêñø)
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõÐÉê× õêñø).
  • spinobulbar muscular atrophy
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Subclavian vein
    ºøÀ幨Á¤¸Æ
    [¿¾ ¿ë¾î] ¼â°ñÇÏÁ¤¸Æ
  • Groove for subclavian vein
    ºøÀ幨Á¤¸Æ°í¶û
    [¿¾ ¿ë¾î] ¼â°ñÇÏÁ¤¸Æ±¸
  • Oblique vein
    ºøÁ¤¸Æ
    [¿¾ ¿ë¾î] »çÁ¤¸Æ
  • Oblique vein (partial)
    ºøÁ¤¸Æ(ºÎºÐ)
    [¿¾ ¿ë¾î] »çÁ¤¸Æ
  • Gonadal vein
    »ý½Ä»ùÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼º¼±Á¤¸Æ
  • Precentral vein of cerebellum
    ¼Ò³úÁ߽ɼҿ±Á¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò³úÁ߽ɼҿ±Á¤¸Æ
  • Sublobular vein
    ¼Ò¿±¹ØÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò¿±ÇÏÁ¤¸Æ
  • Interlobular vein
    ¼Ò¿±»çÀÌÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò¿±°£Á¤¸Æ
  • Intralobular vein
    ¼Ò¿±¼ÓÁ¤¸Æ
    [¿¾ ¿ë¾î] ¼Ò¿±³»Á¤¸Æ
  • Internal jugular vein
    ¼Ó¸ñÁ¤¸Æ
    [¿¾ ¿ë¾î] ³»°æÁ¤¸Æ
  • Internal iliac vein
    ¼Ó¾ûµ¢Á¤¸Æ
    [¿¾ ¿ë¾î] ³»Àå°ñÁ¤¸Æ
  • Internal pudendal vein
    ¼ÓÀ½ºÎÁ¤¸Æ
    [¿¾ ¿ë¾î] ³»À½ºÎÁ¤¸Æ
  • Subcardinal vein
    ¾Æ·¡±âº»Á¤¸Æ
    [¿¾ ¿ë¾î] ÇÏÁÖÁ¤¸Æ
  • Inferior ventricular vein
    ¾Æ·¡³ú½ÇÁ¤¸Æ
    [¿¾ ¿ë¾î] Çϳú½ÇÁ¤¸Æ
  • Inferior ophthalmic vein
    ¾Æ·¡´«Á¤¸Æ
    [¿¾ ¿ë¾î] ÇϾÈÁ¤¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
MSS Marshall-Smith syndrome; massage; Medical Superintendents' Society; Medicare Statistical System; men...
musc muscle, musculature, muscular
MyMD myotonic muscular dystrophy
NFMD National Foundation for Muscular Dystrophy
NMA National Malaria Association; National Medical Association; neurogenic muscular atrophy; N-nitroso-N...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
EHPVO Extrahepatic portal vein obstruction
FV Femoral vein
GCV Great cardiac vein
GCVF Great cardiac vein flow
HV Hepatic vein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • deep lingual vein
    ¼³½ÉÁ¤¸Æ
  • diploic vein
    ÆÇ »çÀÌ Á¤¸Æ, ÆÇ°£ Á¤¸Æ
  • dorsal metacarpal vein
    µîÂÊ ¼ÕÇ㸮 Á¤¸Æ
  • dorsal vein
    ¹èºÎ Á¤¸Æ
  • emissary vein of foramen cecum
    ¸·±¸¸Û À̲ø Á¤¸Æ, ¸Í°ø µµÃâ Á¤¸Æ
    foramen cecumÀ» ÅëÇÏ¿© ºñ°­¼ÓÀÇ Á¤¸Æ°ú su
  • external jugular vein
    ¹Ù±ù ¸ñ Á¤¸Æ, ¿Ü°æ Á¤¸Æ
  • facial diploic vein
    ¾ó±¼ÆÇ »çÀÌ Á¤¸Æ, ¾È¸éÆÇ°£ Á¤¸Æ
  • facial vein
    ¾ó±¼ Á¤¸Æ, ¾È¸é Á¤¸Æ
  • femoral vein
    ´ëÅð Á¤¸Æ
  • inferior basal vein
    ¾Æ·¡ ¹Ù´Ú Á¤¸Æ
  • inferior epigastric vein
    ¾Æ·¡ ¹èº® Á¤¸Æ
    ÇϺ¹º® µ¿¸ÆÀÇ ¹ÝÇà Á¤¸ÆÀ̸ç, ¿ÜÀå°ñ Á¤¸ÆÀ¸·Î °³±¸ÇÑ´Ù.
  • inferior gluteal vein
    ¾Æ·¡ º¼±â Á¤¸Æ
    ÇϵРµ¿¸ÆÀÇ ¹ÝÇà Á¤¸Æ. ´ëÅð ¹èºÎÀÇ ÇÇÇÏ Á¶Á÷ µÐºÎÀÇ ±ÙÀ°À¸·ÎºÎÅÍ Ç÷¾×À» ¸ð¾Æ¼­ ´ëÁ°ñ °øÀ» Áö³­ ÈÄ ÇϳªÀÇ Á¤¸ÆÀ¸·Î ¸¸³­´Ù. ³»Àå°ñ Á¤¸ÆÀ¸·Î °³±¸ÇÑ´Ù.
  • inferior ophthalmic vein
    ÇÏ¾È Á¤¸Æ
    ±ÙÁö ¹× ¸ð¾çü ºÐÁö¿¡ ÀÇÇØ Çü¼ºµÇ¸ç, ÈĹæÀ¸·Î ÁÖÇàÇÏ¿© »ó¾È Á¤¸Æ°ú ¸¸³ª°Å³ª ÇØ¸é Á¤¸Æµ¿À¸·Î Á÷Á¢ °³±¸ÇÑ´Ù.
  • inferior phrenic vein
    ¾Æ·¡ °¡·Î¸· Á¤¸Æ
  • inferior rectal vein
    ¾Æ·¡ °ðâÀÚ Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
Gm type <immunology> Genetically determined allotypic antigens found on IgG of some individuals.
(18 Nov 1997)
Golgi type II neuron <physiology> Nerve cells with short axons which ramify in the gray matter.
(05 Mar 2000)
Golgi type I neuron <physiology> Nerve cells whose long axons leave the gray matter of which they form a part.
(05 Mar 2000)
membrane-type 3 matrix metalloproteinase <enzyme> Sm3 is a soluble form of mt3-mmp, probably an alternatively sliced variant.
Registry number: EC 3.4.24.-
Synonym: mt3-mmp, sm3-mmp
(26 Jun 1999)
membrane-type 4 matrix metalloproteinase <enzyme> Cloned from breast carcinoma.
Registry number: EC 3.4.24.-
Synonym: mt4-mmp, mmp-17 gene product, mmp-17
(26 Jun 1999)
membrane-type matrix metalloproteinase <enzyme> Activates gelatinase a; isolated from a human placenta cdna gene library; contains a transmembrane domain; do not use for any other numbered matrix metalloproteinases; genbank d26512
Registry number: EC 3.4.24.-
Synonym: mt-mmp, mmp-x1 protein, matrix metalloproteinase, membrane-type, mmp14 gene product, mmp-14 gene product, mt1-mmp, matrix metalloproteinase 14, mt2-mmp, mmp15 gene product, mmp16 gene product
(26 Jun 1999)
retroviruses type b, mammalian A genus of the family retroviridae consisting of a few exogenous, vertically transmitted and endogenous viruses of mice. It is associated with mammary carcinoma and T-cell lymphoma.
(12 Dec 1998)
retroviruses type c, avian A genus of the family retroviridae with type c morphology, that causes malignant and other diseases in wild birds and domestic fowl.
(12 Dec 1998)
retroviruses type c, mammalian A genus of retroviridae comprising endogenous sequences in mammals, related reticuloendotheliosis viruses of birds, and a reptilian species. Many species contain oncogenes and cause leukaemias and sarcomas.
(12 Dec 1998)
retroviruses, type d A genus of the family retroviridae consisting of oncogenic exogenous retroviruses that contain type d particles. They include the type species, mason-pfiser monkey virus, isolated from mammary carcinoma and normal tissues in rhesus monkeys, and several other serotypes of simian type d retroviruses (retroviruses type d, simian), all of which cause simian aids (saids) and other malignancies. The permanent human fibroblast virus (pmfv) is also type d. The core of the type d viruses is the intracytoplasmic type a particle and its mechanism of budding from the cell membrane is similar to the type b oncoviruses.
(12 Dec 1998)
retroviruses type d, simian Type d retroviruses that cause simian acquired immunodeficiency syndrome (saids) and malignancies in monkeys. at least five serotypes of srv are recognised: srv-1, srv-2 (retrovirus-d/new england), srv-3 (mason-pfiser monkey virus), srv-4, and srv-5. Subcutaneous fibrosarcoma is associated with srv-1 infection and retroperitoneal fibromatosis is associated with srv-2 infection.
(12 Dec 1998)
grandiose type of paranoid disorder A delusion in which the person believes that he or she possesses some great but unrecognised talent or insight, or has made an important discovery, with subsequent efforts toward official or public recognition.
(05 Mar 2000)
childhood type tuberculosis First infection by Mycobacterium tuberculosis, typically seen in children but also occurs in adults, characterised in the lungs by the formation of a primary complex consisting of small peripheral pulmonary focus with spread to hilar or paratracheal lymph nodes; may cavitate or heal with scarring or may progress.
Synonym: childhood type tuberculosis.
(05 Mar 2000)
pernicious anaemia type rubriblast The earliest of four maturation stages of the megaloblast.
See: erythroblast.
Synonym: pernicious anaemia type rubriblast.
(05 Mar 2000)
persecutory type of paranoid disorder One of the most common of the types of paranoid disorders, it involves a single theme or series of connected themes, such as being conspired against, cheated, spied on, followed, poisoned or drugged, maligned, harassed, or obstructed in the pursuit of long-term goals; small slights may be exaggerated and become the focus of a delusional system.
See: paranoia.
Compare: paranoid personality disorder.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á